- Home
- ESSA vs GNFT Comparison
ESSA vs GNFT Comparison
Compare ESSA & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESSA
- GNFT
- Stock Information
- Founded
- ESSA 1916
- GNFT 1999
- Country
- ESSA United States
- GNFT France
- Employees
- ESSA N/A
- GNFT N/A
- Industry
- ESSA Banks
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESSA Finance
- GNFT Health Care
- Exchange
- ESSA Nasdaq
- GNFT Nasdaq
- Market Cap
- ESSA 195.3M
- GNFT 179.7M
- IPO Year
- ESSA N/A
- GNFT 2019
- Fundamental
- Price
- ESSA $21.23
- GNFT $3.74
- Analyst Decision
- ESSA
- GNFT Strong Buy
- Analyst Count
- ESSA 0
- GNFT 1
- Target Price
- ESSA N/A
- GNFT $13.00
- AVG Volume (30 Days)
- ESSA 43.7K
- GNFT 9.9K
- Earning Date
- ESSA 01-29-2025
- GNFT 09-19-2024
- Dividend Yield
- ESSA 2.86%
- GNFT N/A
- EPS Growth
- ESSA N/A
- GNFT N/A
- EPS
- ESSA 1.74
- GNFT 0.47
- Revenue
- ESSA $67,430,000.00
- GNFT $86,225,222.00
- Revenue This Year
- ESSA N/A
- GNFT $145.20
- Revenue Next Year
- ESSA N/A
- GNFT N/A
- P/E Ratio
- ESSA $11.94
- GNFT $7.89
- Revenue Growth
- ESSA N/A
- GNFT 175.45
- 52 Week Low
- ESSA $15.29
- GNFT $3.35
- 52 Week High
- ESSA $21.62
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- ESSA 58.98
- GNFT 49.41
- Support Level
- ESSA $20.77
- GNFT $3.68
- Resistance Level
- ESSA $21.62
- GNFT $4.03
- Average True Range (ATR)
- ESSA 0.51
- GNFT 0.15
- MACD
- ESSA 0.10
- GNFT 0.05
- Stochastic Oscillator
- ESSA 68.66
- GNFT 57.35
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.